Journal of Clinical Pharmacy and Therapeutics

Papers
(The H4-Index of Journal of Clinical Pharmacy and Therapeutics is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Issue Information70
The Survival Effect of Metformin on Non‐Small Cell Lung Cancer Treated with Chemotherapy: A Systematic Review56
Linezolid‐Induced Lactic Acidosis: Avoiding Concomitant Use With Metformin and Monitoring Linezolid Trough Concentration55
Central nervous system adverse events of ceftazidime/avibactam: A retrospective study using Food and Drug Administration Adverse Event Reporting System52
Cerebrospinal Pharmacokinetic Analysis and Pharmacodynamic Evaluation of Ceftriaxone in Pediatric Patients with Bacterial Meningitis34
Evaluation of desensitization protocols to betalactam antibiotics33
Benefit of medication reviews by renal pharmacists in the setting of a computerized physician order entry system with clinical decision support33
Maintained P2Y 12 inhibitor monotherapy after shorter‐duration of dual antiplatelet therapy in patients undergoing coronary drug‐eluting stents implantation: An upda31
Potentially inappropriate medications and anticholinergic and sedative burden in older patients with haemophilia or von Willebrand disease: The M’HEMORRH‐AGE study31
Use of Analgesic and Anti‐Inflammatory Medicines before and after Initiation of Biological Disease‐Modifying Antirheumatic Drugs for Rheumatoid Arthritis29
Does COVID‐19 increase tacrolimus levels in kidney transplant recipients?27
Successful treatment of a case with synchronous follicular lymphoma and gastric adenocarcinoma with CD19 CAR T cells and literature review27
Visualization of cross‐resistance between antimicrobial agents by asymmetric multidimensional scaling24
Therapeutic Drug Monitoring and Population Pharmacokinetic Analysis of Teicoplanin among Chinese Patients with Gram‐Positive Infections in a Tertiary Hospital23
Preceding bortezomib administration for a certain period reduces the risk of lenalidomide‐induced skin rash23
Effects of New Antiepileptic Drugs on Homocysteine in Epileptic Patients: A Systematic Review and Meta‐Analysis20
Dihydromyricetin Alleviates Nonalcoholic Fatty Liver Disease and Its Associated Metabolic Syndrome by Inhibiting Endoplasmic Reticulum Stress in LDLR−/− Mice Fed with a High‐Fat and High‐Fr18
Cardiovascular toxicities associated with immune checkpoint inhibitors: An updated comprehensive disproportionality analysis of the FDA adverse event reporting system18
0.67802405357361